IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation

Blood

Volumn 128, Issue 10, 2016, Pages 1346-1361

  Sarvaria, Anushruti ^a   Basar, Rafet ^a   Mehta, Rohtesh S ^a   Shaim, Hila ^a   Muftuoglu, Muharrem ^a   Khoder, Ahmad ^b   Sekine, Takuye ^a   Gokdemir, Elif ^a   Kondo, Kayo ^a   Marin, David ^a   Daher, May ^a   Alousi, Amin M ^a   Alsuliman, Abdullah ^a   Liu, Enli ^a   Oran, Betul ^a   Olson, Amanda ^a   Jones, Roy B ^a   Popat, Uday ^a   Hosing, Chitra ^a   Champlin, Richard ^a   Shpall, Elizabeth J ^a   Rezvani, Katayoun ^a   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; CD19 ANTIGEN; CD1D ANTIGEN; CD24 ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; CD40 LIGAND; CD5 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 2; STAT3 PROTEIN; TUMOR NECROSIS FACTOR; IL10 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE SUBPOPULATION; CD4+ T LYMPHOCYTE; CELL CONTACT; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; COCULTURE; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; PHENOTYPE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY B LYMPHOCYTE; T LYMPHOCYTE; ADVERSE EFFECTS; COMPLICATION; FETUS BLOOD; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; SIGNAL TRANSDUCTION; YOUNG ADULT;

ADULT; AGED; B-LYMPHOCYTES, REGULATORY; CD4-POSITIVE T-LYMPHOCYTES; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; FETAL BLOOD; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 85017160282     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2016-01-695122     Document Type: Article

References (47)

1. Wildes TM, Stirewalt DL, Medeiros B, Hurria A. Hematopoietic stem cell transplantation for hematologic malignancies in older adults: geriatric principles in the transplant clinic. J Natl Compr Canc Netw. 2014;12(1):128-136.
2. Koh LP, Chao N. Haploidentical hematopoietic cell transplantation. Bone Marrow Transplant. 2008;42(suppl 1):S60-S63.
3. Beaudette-Zlatanova BC, Le PT, Knight KL, et al. A potential role for B cells in suppressed immune responses in cord blood transplant recipients. Bone Marrow Transplant. 2013;48(1): 85-93.
4. Komanduri KV, St John LS, de Lima M, et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood. 2007;110(13):4543-4551.
5. Stanevsky A, Goldstein G, Nagler A. Umbilical cord blood transplantation: pros, cons and beyond. Blood Rev. 2009;23(5): 199-204.
6. Cutler C, Stevenson K, Kim HT, et al. Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis. Bone Marrow Transplant. 2011; 46(5):659-667.
7. Ballen KK, Spitzer TR, Yeap BY, et al. Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant. 2007;13(1):82-89.
8. Shimabukuro-Vornhagen A, Hallek MJ, Storb RF, von Bergwelt-Baildon MS. The role of B cells in the pathogenesis of graft-versus-host disease. Blood. 2009;114(24):4919-4927.
9. Rezvani K, Mielke S, Ahmadzadeh M, et al. High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood. 2006;108(4):1291-1297.
10. Kapur R, Ebeling S, Hagenbeek A. B-cell involvement in chronic graft-versus-host disease. Haematologica. 2008;93(11):1702-1711.
11. Allen JL, Fore MS, Wooten J, et al. B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways. Blood. 2012;120(12):2529-2536.
12. Sarantopoulos S, Blazar BR, Cutler C, Ritz J. B cells in chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2015;21(1):16-23.
13. Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunol. 2006;176(2):705-710.
14. DiLillo DJ, Matsushita T, Tedder TF. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci. 2010;1183:38-57.
15. Yang M, Rui K, Wang S, Lu L. Regulatory B cells in autoimmune diseases. Cell Mol Immunol. 2013; 10(2):122-132.
16. Tedder TF. B10 cells: a functionally defined regulatory B cell subset. J Immunol. 2015;194(4): 1395-1401.
17. He Y, Qian H, Liu Y, Duan L, Li Y, Shi G. The roles of regulatory B cells in cancer. J Immunol Res. 2014;2014:215471.
18. Khoder A, Sarvaria A, Alsuliman A, et al. Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD. Blood. 2014;124(13):2034-2045.
19. + and plasmablast-like regulatory B cells in human chronic graft-versus-host disease. Blood. 2015;125(11):1830-1839.
20. Le Huu D, Matsushita T, Jin G, et al. Donorderived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease. Blood. 2013;121(16): 3274-3283.
21. Mauri C, Blair PA. The incognito journey of a regulatory B cell. Immunity. 2014;41(6):878-880.
22. Blair PA, Noreña LY, Flores-Borja F, et al. CD19 (+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity. 2010;32(1):129-140.
23. Iwata Y, Matsushita T, Horikawa M, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood. 2011;117(2):530-541.
24. Bouaziz JD, Calbo S, Maho-Vaillant M, et al. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol. 2010;40(10):2686-2691.
25. Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Identification and characterization of circulating human transitional B cells. Blood. 2005;105(11):4390-4398.
26. Marie-Cardine A, Divay F, Dutot I, et al. Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation. Clin Immunol. 2008;127(1):14-25.
27. Cuss AK, Avery DT, Cannons JL, et al. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J Immunol. 2006;176(3):1506-1516.
28. Ha YJ, Mun YC, Seong CM, Lee JR. Characterization of phenotypically distinct B-cell subsets and receptor-stimulated mitogenactivated protein kinase activation in human cord blood B cells. J Leukoc Biol. 2008;84(6): 1557-1564.
29. Palanichamy A, Barnard J, Zheng B, et al. Novel human transitional B cell populations revealed by B cell depletion therapy. J Immunol. 2009; 182(10):5982-5993.
30. Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol. 2012;30:221-241.
31. Lucchini G, Perales MA, Veys P. Immune reconstitution after cord blood transplantation: peculiarities, clinical implications and management strategies. Cytotherapy. 2015;17(6): 711-722.
32. Minguela A, Marín L, Torío A, et al. CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant. Hum Immunol. 2000; 61(7):658-669.
33. Jago CB, Yates J, Câmara NO, Lechler RI, Lombardi G. Differential expression of CTLA-4 among T cell subsets. Clin Exp Immunol. 2004; 136(3):463-471.
34. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008; 8(7):523-532.
35. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133(5):775-787.
36. Mayne CG, Williams CB. Induced and natural regulatory T cells in the development of inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(8):1772-1788.
37. Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A, Kaufman DL. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol. 2001;167(2):1081-1089.
38. Mann MK, Maresz K, Shriver LP, Tan Y, Dittel BN. B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J Immunol. 2007;178(6): 3447-3456.
39. Saliba RM, Rezvani K, Leen A, et al. General and virus-specific immune cell reconstitution after double cord blood transplantation. Biol Blood Marrow Transplant. 2015;21(7):1284-1290.
40. Nakatani K, Imai K, Shigeno M, et al. Cord blood transplantation is associated with rapid B-cell neogenesis compared with BM transplantation. Bone Marrow Transplant. 2014;49(9):1155-1161.
41. Yamashita K, Choi U, Woltz PC, et al. Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells. Blood. 2004; 103(10):3986-3988.
42. Jacobson CA, Sun L, Kim HT, et al. Posttransplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2014; 20(5):668-675.
43. Menon M, Blair PA, Isenberg DA, Mauri C. A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus. Immunity. 2016; 44(3):683-697.
44. Miyashita T, McIlraith MJ, Grammer AC, et al. Bidirectional regulation of human B cell responses by CD40-CD40 ligand interactions. J Immunol. 1997;158(10):4620-4633.
45. Rosser EC, Oleinika K, Tonon S, et al. Regulatory B cells are induced by gut microbiota-driven interleukin-1β and interleukin-6 production. Nat Med. 2014;20(11):1334-1339.
46. Rosser EC, Mauri C. Regulatory B cells: origin, phenotype, and function. Immunity. 2015;42(4): 607-612.
47. Yoshizaki A, Miyagaki T, DiLillo DJ, et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature. 2012;491(7423):264-268.